TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis

被引:21
|
作者
Soraru, Gianni [1 ]
Orsetti, Valeria [1 ]
Buratti, Emanuele [3 ]
Baralle, Francisco [3 ]
Cima, Valentina [1 ]
Volpe, Marco [1 ]
D'Ascenzo, Carla [1 ]
Palmieri, Arianna [1 ]
Koutsikos, Kostantinos [2 ]
Pegoraro, Elena [1 ]
Angelini, Corrado [1 ]
机构
[1] Univ Padua, Dept Neurol Sci, Padua, Italy
[2] IRCSS San Camillo, Venice, Italy
[3] ICGEB, Trieste, Italy
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2010年 / 11卷 / 1-2期
关键词
TDP-43; amyotrophic lateral sclerosis; skeletal muscle; FRONTOTEMPORAL LOBAR DEGENERATION; TAR-DNA-BINDING; MUTATIONS; PROGRANULIN; PROTEIN-43; DIAGNOSIS; NUCLEAR; DISEASE;
D O I
10.3109/17482960902810890
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
TAR DNA binding protein (TDP-43) is the pathologic substrate of neuronal and glial aggregates in amyotrophic lateral sclerosis (ALS). Pathologic TDP-43 is hyperphosphorylated and cleaved to generate abnormal protein species that accumulate in the cytoplasm. To assess the hypothesis of TDP-43 pathology as a systemic disorder in ALS we analysed the immunohistochemical and biochemical profile of TDP-43 in muscle biopsies of 30 ALS patients and 30 controls. In all ALS muscle biopsies we observed that TDP-43 was constantly present in an intranuclear localization and TDP-43 Western blotting showed only a 43-KDa band as controls. Our results suggest that TDP-43 pathology is probably confined to the central nervous system in ALS.</.
引用
收藏
页码:240 / U35
页数:5
相关论文
共 50 条
  • [41] Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions
    Mori, Fumiaki
    Tada, Mari
    Kon, Tomoya
    Miki, Yasuo
    Tanji, Kunikazu
    Kurotaki, Hidekachi
    Tomiyama, Masahiko
    Ishihara, Tomohiko
    Onodera, Osamu
    Kakita, Akiyoshi
    Wakabayashi, Koichi
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [42] Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases
    Geser, Felix
    Martinez-Lage, Maria
    Kwong, Linda K.
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    JOURNAL OF NEUROLOGY, 2009, 256 (08) : 1205 - 1214
  • [43] Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
    Hasegawa, Masato
    Ara, Tetsuaki
    Nonaka, Takashi
    Kametani, Fuyuki
    Yoshida, Mari
    Hashizume, Yoshio
    Beach, Thomas G.
    Buratti, Emanuele
    Baralle, Francisco
    Morita, Mitsuya
    Nakano, Imaharu
    Oda, Tatsuro
    Tsuchiya, Kuniaki
    Akiyama, Haruhiko
    ANNALS OF NEUROLOGY, 2008, 64 (01) : 60 - 70
  • [44] Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
    Riva, Nilo
    Gentile, Francesco
    Cerri, Federica
    Gallia, Francesca
    Podini, Paola
    Dina, Giorgia
    Falzone, Yuri Matteo
    Fazio, Raffaella
    Lunetta, Christian
    Calvo, Andrea
    Logroscino, Giancarlo
    Lauria, Giuseppe
    Corbo, Massimo
    Iannaccone, Sandro
    Chio, Adriano
    Lazzerini, Alberto
    Nobile-Orazio, Eduardo
    Filippi, Massimo
    Quattrini, Angelo
    BRAIN, 2022, 145 (01) : 276 - 284
  • [45] "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis
    Aksoy, Yagiz Alp
    Deng, Wei
    Stoddart, Jack
    Chung, Roger
    Guillemin, Gilles
    Cole, Nicholas James
    Neely, Graham Gregory
    Hesselson, Daniel
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2020, 126
  • [46] A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
    Mitra, Joy
    Hegde, Muralidhar L.
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2019, 13
  • [47] Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis
    Takeda, Takahiro
    Uchihara, Toshiki
    Kawamura, Shunji
    Ohashi, Takashi
    CLINICAL NEUROPATHOLOGY, 2014, 33 (01) : 65 - 67
  • [48] TDP-43 aggregation as a possible therapeutic target for Amyotrophic Lateral Sclerosis
    Cragnaz, Lucia
    Romano, Valentina
    Baralle, Francisco Ernesto
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (04): : 649 - 655
  • [49] TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis
    Beyer, Leon
    Guenther, Rene
    Koch, Jan Christoph
    Klebe, Stephan
    Hagenacker, Tim
    Lingor, Paul
    Biesalski, Anne-Sophie
    Hermann, Andreas
    Nabers, Andreas
    Gold, Ralf
    Toenges, Lars
    Gerwert, Klaus
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (01): : 271 - 277
  • [50] TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
    Sarah Lépine
    Maria José Castellanos-Montiel
    Thomas Martin Durcan
    Translational Neurodegeneration, 11